MoneyWorks4Me

Kimia Biosciences - Quaterly Results

11 Aug 2026 Evaluate
The sales slipped to Rs. 207.23 millions for the June 2026 quarter as against Rs. 235.84 millions during the year-ago period.Profit after Tax for the quarter ended June 2026 saw a decline of -41.23% from Rs. 6.04 millions to Rs. 3.55  millions.Operating Profit reported a sharp decline to 24.27 millions from 33.73 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 207.23 235.84 -12.13 207.23 235.84 -12.13 1148.84 1189.21 -3.39
Other Income 0.81 8.47 -90.44 0.81 8.47 -90.44 16.22 13.20 22.88
PBIDT 24.27 33.73 -28.05 24.27 33.73 -28.05 158.89 215.70 -26.34
Interest 8.31 17.47 -52.43 8.31 17.47 -52.43 35.16 45.57 -22.84
PBDT 15.96 16.26 -1.85 15.96 16.26 -1.85 123.73 170.13 -27.27
Depreciation 11.07 9.35 18.40 11.07 9.35 18.40 39.13 33.79 15.80
PBT 4.89 6.91 -29.23 4.89 6.91 -29.23 84.60 136.34 -37.95
TAX 1.34 0.87 54.02 1.34 0.87 54.02 10.26 40.22 -74.49
Deferred Tax 1.34 0.87 54.02 1.34 0.87 54.02 10.26 40.22 -74.49
PAT 3.55 6.04 -41.23 3.55 6.04 -41.23 74.34 96.12 -22.66
Equity 47.31 47.31 0.00 47.31 47.31 0.00 47.31 47.31 0.00
PBIDTM(%) 11.71 14.30 -18.11 11.71 14.30 -18.11 13.83 18.14 -23.75

Kimia Biosciences Share Price

27.92 0.74 (2.72%)
21-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.90
Dr. Reddys Labs. 1175.00
Cipla 1426.20
Lupin 2193.00
Zydus Lifesciences 1120.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: